UroTiss GmbH is a pharmaceutical company with headquarters in the German city of Dortmund. Complying with current Good Manufacturing Practices (GMP), UroTiss delivers products of extreme safety and quality. Our company has patented technologies in the growing field of tissue engineering, where the patient’s own cells are used in the treatment of his or her urological disorder.
Current indications for the first product developed by our company include the repair of urethral strictures and hypospadias. Patients have the option of urethral reconstruction with an autologous MukoCell® cell transplant since 2010. Urethral repair with MukoCell® is a gentle alternative to conventional transplantation with native buccal mucosa.